AAM's adjusted earnings per share in the fourth quarter 2021 was a loss of $0.09 per share.
Adjusted lost per share for the fourth quarter of 2021 was $0.09, compared to $0.51 earnings per share in the fourth quarter of 2020.
AAM's adjusted earnings per share in the fourth quarter 2021 was a loss of $0.09 per share.
Adjusted lost per share for the fourth quarter of 2021 was $0.09, compared to $0.51 earnings per share in the fourth quarter of 2020.
Taking all these aforementioned items into account, including the pension settlement charge, our GAAP net loss was $46 million or $0.41 per share in the fourth quarter of 2021, compared to an income of $36 million or $0.30 per share in the fourth quarter of 2020.
AAM's fourth quarter 2021 sales were $1.24 billion, and for the full year 2021, AAM's sales were approximately $5.2 billion.
In the fourth quarter of 2021, AAM sales were $1.24 billion, compared to $1.44 billion in the fourth quarter of 2020.
And AAM is targeting sales in the range of $5.6 billion to $5.9 billion, adjusted EBITDA of approximately $800 million to $875 million, adjusted free cash flow approximately $300 million to $375 million.
From an EBITDA perspective, we're expecting adjusted EBITDA in the range of $800 million to $875 million.
And AAM is targeting sales in the range of $5.6 billion to $5.9 billion, adjusted EBITDA of approximately $800 million to $875 million, adjusted free cash flow approximately $300 million to $375 million.
As for sales, we are targeting the range of $5.6 billion to $5.9 billion for 2022.
And from an end market perspective, we forecast production at approximately 14.8 million to 15.2 million units for our primary North American market.
This sales target is based upon North American production estimates of 14.8 million to 15.2 million units, new business backlog launches of $175 million and attrition of approximately $100 million.
And AAM is targeting sales in the range of $5.6 billion to $5.9 billion, adjusted EBITDA of approximately $800 million to $875 million, adjusted free cash flow approximately $300 million to $375 million.
From an EBITDA perspective, we're expecting adjusted EBITDA in the range of $800 million to $875 million.
AAM expects our gross new business backlog covering three-year period of 2022 through 2024 to be approximately $700 million.
We expect the launch case of this backlog to be $175 million in 2022, $325 million in 2023, and $200 million in 2024.
This sales target is based upon North American production estimates of 14.8 million to 15.2 million units, new business backlog launches of $175 million and attrition of approximately $100 million.
